【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Zenpep/ Ultresa/ Ultrase/ Ultrase MT
04.1.2 Colomycin/ Colobreathe
04.1.3 Pulmozyme
04.1.4 Cayston
04.1.5 TOBI/ TOBI Podhaler
04.1.6 Kalydeco
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Understanding the Disease
07.2 Pathophysiology
07.3 Epidemiology
07.3.1 Global
07.3.2 North America
07.3.3 Europe
07.3.4 Africas
07.3.5 Latin America
07.3.6 Middle East
07.3.7 Asia and Oceania
07.4 Diagnosis
07.4.1 Newborn Screening
07.4.2 Carrier Testing
07.4.3 Antenatal Testing
07.4.4 Other Tests
07.5 Manifestations of Cystic Fibrosis
07.6 Economic Burden
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Molecule Type
09.1 Biologics
09.1.1 Enzymes
09.2 Small Molecules
09.2.1 CFTR Modulator
09.2.2 Antibiotics
10.Market Segmentation by Route of Administration
10.1 Oral
10.2 Parenteral
10.3 Topical
11.Market Segmentation by Dosage Form
11.1 Solid
11.2 Liquid
12.Geographical Segmentation
12.1 Cystic Fibrosis Market in the Americas
12.1.1 Cystic Fibrosis Market in the US
12.1.2 Cystic Fibrosis Market in the Latin America
12.1.3 Cystic Fibrosis Market in the Canada
12.2 Cystic Fibrosis Market in the EMEA Region
12.2.1 Market Size and Forecast
12.3 Cystic Fibrosis Market in the APAC Region
12.3.1 Market Size and Forecast
13.Key Leading Countries
13.1 US
13.2 UK
13.3 France
13.4 Canada
13.5 Italy
14.Buying Criteria
15.Market Growth Drivers
16.Drivers and their Impact
17.Market Challenges
18.Impact of Drivers and Challenges
19.Market Trends
20.Trends and their Impact
21.Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.2.1 F. Hoffmann-La Roche
21.2.2 Novartis
21.2.3 Vertex Pharmaceuticals
21.2.4 Actavis
21.2.5 Gilead Sciences
21.3 Other and Future Prominent Vendors
22.Key Vendor Analysis
22.1 Actavis
22.1.1 Key Facts
22.1.2 Business Description
22.1.3 Business Segmentation
21.1.4 Revenue by Business Segmentation
22.1.5 Revenue Comparison 2013 and 2014
22.1.6 Sales by Geography
22.1.7 Business Strategy
22.1.8 Key Developments
22.1.9 SWOT Analysis
22.2 F. Hoffmann-La Roche
22.2.1 Key Facts
22.2.2 Business Description
22.2.3 Business Segmentation
22.2.4 Revenue by Business Segmentation
22.2.5 Revenue Comparison 2013 and 2014
22.2.6 Sales by Geography
22.2.7 Business Strategy
22.2.8 Key Developments
22.1.9 SWOT Analysis
22.3 Gilead Sciences
22.3.1 Key Facts
22.3.2 Business Description
22.3.3 Business Segmentation
22.3.4 Revenue by Business Segmentation
22.3.5 Revenue Comparison 2013 and 2014
22.3.6 Sales by Geography
22.3.7 Business Strategy
22.3.8 Key Developments
22.3.9 SWOT Analysis
22.4 Novartis
22.4.1 Key Facts
22.4.2 Business Description
21.4.3 Business Segmentation
22.4.4 Revenue by Business Segmentation
22.4.5 Revenue Comparison 2013 and 2014
22.4.6 Sales by Geography
22.4.7 Business Strategy
22.4.8 Key Developments
22.4.9 SWOT Analysis
22.5 Vertex Pharmaceuticals
22.5.1 Key Facts
22.5.2 Business Description
22.5.3 Business Segmentation
22.5.4 Revenue by Business Segmentation
22.5.5 Revenue Comparison 2013 and 2014
22.5.6 Sales by Geography
22.5.7 Business Strategy
22.5.8 Key Developments
22.5.9 SWOT Analysis
23.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot Of Cystic Fibrosis Disease
Exhibit 3: Defects Caused by CFTR Mutation
Exhibit 4: Epidemiology of Cystic Fibrosis in the World 2012
Exhibit 5: Prevalence of Cystic Fibrosis by Country 2014
Exhibit 6: Prevalence Number of Cystic Fibrosis by Country 2014
Exhibit 7: Snapshot of US Prevalence of Cystic Fibrosis 2014
Exhibit 8: Forecast of Cystic Fibrosis Prevalence in US 2014-2019
Exhibit 9: Epidemiology Based on the Education Level in US, 2011
Exhibit 10: Epidemiology based on the Marital Status in US, 2011
Exhibit 11: Epidemiology based on the Employment Status in US, 2011
Exhibit 12: Forecast of Cystic Fibrosis Prevalence in Canada 2014-2019
Exhibit 13: Forecast of Cystic Fibrosis Prevalence in the UK 2014-2019
Exhibit 14: Age Distribution at Death for Cystic Fibrosis Patients in UK, 2013
Exhibit 15: Age Distribution by Gender for Cystic Fibrosis Patients in the UK, 2013
Exhibit 16: Age Distribution by Sex for Cystic Fibrosis Patients in the UK, 2013
Exhibit 17: Diagnosis of Cystic Fibrosis
Exhibit 18: The Manifestations of Cystic Fibrosis
Exhibit 19: Snapshot of the Economic Burden of Cystic Fibrosis
Exhibit 20: Snapshot of Global Cystic Fibrosis Market 2014
Exhibit 21: Global Cystic Fibrosis Market 2014-2019 (US$ million)
Exhibit 22: Global Cystic Fibrosis Market Segmentation By Class of Drugs
Exhibit 23: Global Cystic Fibrosis Drugs Market Segmentation by Molecule Type 2014
Exhibit 24: Global Cystic Fibrosis Market Segmentation By Route Of Administration
Exhibit 25: Global Cystic Fibrosis Drugs Market Segmentation by Route of Administration 2014
Exhibit 26: Global Cystic Fibrosis Market Segmentation by Dosage Form
Exhibit 27: Global Cystic Fibrosis Drugs Market Segmentation by Dosage Form 2014
Exhibit 28: Global Cystic Fibrosis Market by Geographical Segmentation 2014 and 2019
Exhibit 29: Global Cystic Fibrosis Market Revenue by Geographical Segmentation 2014-2019 (US$ million)
Exhibit 30: Global Cystic Fibrosis Market Growth Rate by Region 2014-2019
Exhibit 31: Revenue (US$ million) and CAGR of Global Cystic Fibrosis Market by Geographical Segments 2014 and 2019
Exhibit 32: Global Cystic Fibrosis Market by Country/Region 2014
Exhibit 33: Global Cystic Fibrosis Market by Country/Region 2014 (US$ million)
Exhibit 34: Cystic Fibrosis Market in the Americas 2014-2019 (US$ million)
Exhibit 35: Cystic Fibrosis Market Revenue in the Americas 2014-2019
Exhibit 36: Cystic Fibrosis Market Growth Rate in the Americas 2014-2019
Exhibit 37: Cystic Fibrosis Market in the Americas by Region 2014 and 2019
Exhibit 38: Revenue (US$ million) and CAGR of Cystic Fibrosis Market in the Americas by Regions 2014 and 2019
Exhibit 39: Cystic Fibrosis Market in the US 2014-2019 (US$ million)
Exhibit 40: Cystic Fibrosis Market in the Latin America 2014-2019 (US$ million)
Exhibit 41: Cystic Fibrosis Market in Canada 2014-2019 (US$ million)
Exhibit 42: Cystic Fibrosis Market in EMEA 2014-2019 (US$ million)
Exhibit 43: Cystic Fibrosis Market in EMEA by Country/Region 2014
Exhibit 44: Cystic Fibrosis Market in APAC 2014-2019 (US$ million)
Exhibit 45: Buying Criteria of Global Cystic Fibrosis Market
Exhibit 46: Global Cystic Fibrosis Market Share Analysis 2014
Exhibit 47: Global Sales Comparison of Pulmozyme 2013 vs 2012 (US$ Million)
Exhibit 48: Quarterly Sales Comparison of Pulmozyme in the US 1994-2008 (US$ Million)
Exhibit 49: Quarterly Sales Comparison of Pulmozyme Sales to Collaborators 1997-2008 (US$ Million)
Exhibit 50: Quarterly Sales Comparison of Pulmozyme Total Sales 1994-2008 (US$ Million)
Exhibit 51: Total Global Sales Comparison of Pulmozyme 1994-2008 (US$ Million)
Exhibit 52: TOBI Podhaler
Exhibit 53: YoY Sales Comparison of TOBI and TOBI Podhaler 2006-2013 (US$ Million)
Exhibit 54: YoY Sales Comparison of Kalydeco 2012-2013 (US$ Million)
Exhibit 55: Actavis: Business Segmentation 2014
Exhibit 56: Actavis: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 57: Actavis : Sales by Geography (in US$ million)
Exhibit 67: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2013 and 2014
Exhibit 68: F. Hoffmann-La Roche Ltd.: Sales by Geography 2014 (Pharmaceuticals Division)
Exhibit 69: F. Hoffmann-La Roche Ltd.: Sales by Geography 2014 (Diagnostics Division)
Exhibit 63: Gilead Sciences: Business Segmentation by Revenue 2014
Exhibit 64: Gilead Sciences: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 65: Gilead Sciences: Sales by Geography 2014
Exhibit 18: Novartis AG: Business Segmentation
Exhibit 19: Novartis AG: Revenue by Business Segmentation 2014
Exhibit 20: Novartis AG: Revenue by Business Segmentation 2013 and 2014 (US$ million)
Exhibit 21: Novartis AG: Revenue by Geographical Segmentation 2014
Exhibit 63: Vertex Pharmaceuticals: Business Segmentation by Revenue 2014
Exhibit 64: Vertex Pharmaceuticals: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 65: Vertex Pharmaceuticals: Sales by Geography 2014
【レポート販売概要】
■ タイトル：嚢胞性線維症（CF症）治療薬の世界市場■ 英文：Global Cystic Fibrosis Market 2015-2019
■ 発行日：2014年12月17日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4842
■ 調査対象地域：グローバル
- 医療コーティングの世界市場予測：親水性塗料、疎水性塗料The global medical coatings market is projected to grow at a CAGR of 7.04% from 2016 to reach USD 15.15 Billion by 2021. The market is highly driven by the awareness about healthcare acquired infections and minimally invasive surgery. Another prime factor that is expected to bring momentum to this market is the increasing ageing population globally and rising awareness about health-care and govern …
- 移動式クレーンの世界市場2017-2021ABSTRACTAbout Mobile Crane A mobile crane is a lifting device, which incorporates a cable-controlled crane mounted on rubber-tired carriers or crawlers or a hydraulic-powered crane with a telescoping boom. It is designed for easy transportation between the various operating locations by road. It is designed to be used with different types of loads and cargo, with little or no setup or assembly. Mo …
- 世界のモバイル広告市場分析、展望及び予測Mobile advertising has evolved beyond an experiment to become a legitimate marketing channel for mainstream advertisers. However, the mobile channels remains challenged in certain key areas such as certain industry vertical proof points and ROI. This research focuses on the challenges and opportunities within mobile marketing and advertising in 2014 and beyond. The report includes market analysis, …
- 世界のLTEベースステーション(eNodeB)市場動向（2012-2016）TechNavio's analysts forecast the Global LTE Base Station (eNodeB) market to grow at a CAGR of 49.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the inexorable rise of data. The Global LTE Base Station (eNodeB) market has also been witnessing the deployment in the re-farmed spectrum. However, the spectrum fragmentation could pose a challenge to th …
- 世界のエトキシレート市場2015The Global Ethoxylates Industry Report 2015 is a professional and in-depth study on the current state of the Ethoxylates industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Ethoxylates market analysis is provided for the international markets including development trends, competitive landscape analysis …
- UCaaSの世界市場2017-2021ABSTRACTAbout Unified Communication UCaaS is a cloud-based deployment model of unified communications (UC) technology such as enterprise audio and video conferencing, hosted VoIP, and cloud private branch exchange (PBX). UCaaS is implemented in enterprises to communicate and collaborate globally in a cloud-based ICT ecosystem. Technavio’s analysts forecast the global unified communication as a ser …
- 通信産業向けセキュリティソフトウェアの世界市場About security services Security software comprise a suite of security products. Their scope encompasses several areas such as data protection, compliance, architecture, email security, web security, governance, data loss prevention, security information and event management, and identity and access. A security software solution provides several features such as encryption, endpoint monitoring, id …
- メシフランの世界市場分析：用途別（食品･飲料、医薬品、動物用飼料）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、中南米、MEA）、競争戦略、セグメント予測、2014-2025The global mesifurane market is expected to reach USD 153.8 million by 2025, according to a new report by Grand View Research, Inc. Inclination of consumers towards high-quality processed foods in emerging economies such as India and China is likely to boost demand for fresh and aromatic food additives such as mesifurane. The compound occurs naturally in fruits such as strawberries, and has a stro …
- 質量分析法（MS）の世界市場予測（～2022年）：種類、用途、地域別分析The global mass spectrometry market is expected to reach USD 5.27 Billion by 2022 from USD 3.68 Billion in 2017, at a CAGR of 7.4%. The growth of this market is majorly driven by technological advancements in mass spectrometry, government initiatives for pollution control and environmental testing, increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety an …
- ワイヤレスネットワークセキュリティの世界市場2015-2022According to Stratistics MRC, the Global Wireless Network Security Market is valued at $9.56 billion in 2015 and is expected to grow at a CAGR of 13.82% to reach $23.67 billion by 2022. Increasing count of wireless networks in enterprises, rising demand for WLAN security systems, growing adoption of smart phones at work places and encouraging government regulations are some of the key factors fost …
- 低浸透インクの世界市場予測（～2022年）：プロセス（グラビア印刷、フレキソ印刷、オフセット印刷、デジタル印刷）、需要先、地域別分析The low migration inks market is projected to reach USD 2.72 Billion by 2022 from USD 1.82 Billion in 2017, at a CAGR of 8.4% between 2017 and 2022. Migration of inks is a major issue in applications such as food, beverages, and cosmetics. Inks with high molecular weight are used for printing and labeling to avoid contamination in these products. Inks with high molecular weight using selected comp …
- 世界の電子パスポート（e-passport）市場動向（2012-2016）TechNavio's analysts forecast the Global e-passport market to grow at a CAGR of 32.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need to comply with government regulations. The Global e-passport market has also been witnessing the increasing use of e-passport as a standard travel document. However, the high implementation costs of …
- 高電圧MOSFETのグローバル市場動向（2014-2018）About High-voltage MOSFETs A MOSFET is a three terminal semiconductor component and a type of transistor which is used for amplifying electronic signals or switching electronic signals. MOSFETs are mainly used for voltage conversions. MOSFETs are basically silicon-based semiconductor components used in electronic devices. Further, MOSFETs have three terminals, namely source, gate, and drain. High- …
- 電力変圧器の世界市場• Do you need definitive power transformers market data?• Succinct power transformers market analysis? • Technological insight? • Clear competitor analysis? • Actionable business recommendations? Read on to discover how this definitive report can transform your own research and save you time. The increased focus on a more efficient energy grid infrastructure has led Visiongain to publish this time …
- フルーツティーの世界市場2019-2023Global Fruit Tea Market: About this market Technavio’s fruit tea market analysis considers sales from both conventional fruit tea and organic fruit tea. Our analysis also considers the sales of fruit tea in APAC, Europe, North America, South America, and MEA. In 2018, the conventional fruit tea segment had a significant market share, and this trend is expected to continue over the forecast period. …
